KLRK1 and gastric cancer: Given the vital role of NK cells in anti-tumor immunity, therapeutic strategies aimed at restoring or enhancing NK cell function, either by boosting NKG2D activity or by counteracting the immunosuppressive effects of cytokines and PGE2, could also offer promising new avenues for the treatment of gastric cancer.